Resources

To inform efforts to accelerate effective and equitable coverage of lifesaving maternal, newborn, and child health interventions that are integrated into primary health care systems, PATH undertook a rapid but rigorous analysis of the status of access, uptake, implementation, and coverage of nine proven interventions. We were able to identify more than 11,000 data points and create 14 interactive dashboards to visualize the status of these interventions along the pathway to scale-up (available at bit.ly/mnchassettracker). This brief summarizes key findings and offers policy recommendations for global and national decision-makers.

The UK Government established the Fleming Fund to respond to the global threat of antimicrobial resistance (AMR), a One Health Initiative to fight AMR in low- and middle-income countries. In Vietnam, with support from the Fleming Fund and FHI 360 Vietnam, PATH will work and support the Vietnam Medical Services Administration, the Department of Animal Health, and surveillance laboratories to strengthen data systems to help combat AMR.

As COVID-19 spreads around the world, PATH in India is working to lessen its impact. PATH is partnering with governments, innovators, and peers across the country to plug the gaps in health systems and provide support to develop and strengthen systems that are preventing, identifying, tracking, and responding to the COVID-19 outbreak. This includes policy, preparedness, information, education and communications support, capacity-building and strengthening, digital and data strategies, accelerating innovations, and collaboration with partners.

SARS-CoV-2: PATH’S RESPONSEFor more than 40 years, PATH has been working to increase access to health interventions, improve quality of care, and achieve health equity. With expertise in global health security, vaccines and immunization, data systems, surveillance and diagnostics under one roof, health experts at PATH can implement holistic solutions. Today, our global team of more than 1,400 is at work in 70 countries, partnering across ministries, governments, and the private sector to develop and roll out lifesaving vaccines, create affordable diagnostic tools, and scale our impact through advocacy and policy efforts.For the COVID-19 outbreak, we are supporting the immediate response by expanding our existing work to help countries be ready to deploy testing, surveillance, mitigation strategies, and solutions to improve health systems. We’re also helping countries identifying health systems strengthening opportunities that will address longer-term concerns.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2019 with a focus on evaluating progress and analyzing impact of grants funded through the 2017-2019 allocation and implemented during 2018-2019. Findings were structured around three out of the four Global Fund strategic objectives (SOs): grant implementation and contribution to disease impact (SO1); grant contribution to national Resilient and Sustainable Systems for Health outcomes (SO2); and grant contribution to national program key population, human rights, and gender-related outcomes (SO3).